1. Mayo Clinic Cancer Center, Rochester, MN;
2. IRCCS San Martino - IST, Genoa, Italy;
3. Wayne State University, Karmanos Cancer Institute, Detroit, MI;
4. Department of Gastroenterology and Gastrointestinal Oncology, National Cancer Center Hospital, Chiba, Japan;
5. University of Glasgow, Cancer Research UK Clinical Trials Unit, Glasgow, United Kingdom;
6. Hopital Européen Georges Pompidou, Paris, France;
7. University of Heraklion, Athens, Greece;
8. University of Oxford, Oxford, United Kingdom;
9. Ospedale Papa Giovanni XXIII, Bergamo, Italy;
10. Dana-Farber Cancer Institute, Boston, MA;
11. Methodology and Quality of Life Unit, Department of Oncology, INSERM UMR 1098, University Hospital of Besancon; French National Platform Quality of Life and Cancer, Besançon, France;
12. Department of Surgical Oncology and Vascular Surgery, the University of Tokyo, Tokyo, Japan;
13. Bioclinic Thessaloniki Medical Oncology Unit, Thessaloniki, Greece;
14. Mayo Clinic, Rochester, MN;
15. Duke University, Durham, NC;
16. IRCCS - Mario Negri Institute for Pharmacological Research, Milan, Italy;
17. Medical Oncology Department, Saint-Antoine Hospital, Paris, France;
18. University Hospital Southampton NHS Foundation Trust, Southampton, United Kingdom;